Neovasc Inc. (Neovasc), formerly known as Medical Ventures Corp., is a medical device company engaged in the development and manufacture of cardiovascular and surgical products. The company`s devices are useful to the doctors for the treatment of a broad range of health related problems such as heart disease, hernias and obesity. Its prinicpal product line includes Neovasc Reducer for the treatment of refractory angina and PeriPatch implantable biological tissue. The company operates in the US, Canada, Mexico, Brazil and selected European markets. Neovasc is headquartered in British Columbia, Canada.The company reported revenues of (Canadian Dollars) CAD 1.55 million during the fiscal year ended December 2008, an increase of 1.84% over 2007. The operating loss of the company was CAD 34.66 million during the fiscal year 2008, as compared to an operating loss of CAD 7.91 million during 2007. The net loss of the company was CAD 34.26 million during the fiscal year 2008, as compared to a net loss of CAD 7.83 million during 2007.